COMMUNIQUÉS West-GlobeNewswire

Invuity Announces 2018 Second Quarter, Six-Month Financial Results
02/08/2018
SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six [...]
OpGen Reports Second Quarter 2018 Financial Results And Provides Business Update
02/08/2018
Revenue increases 12% to $0.8 million, net loss narrows 21% to $3.3 million Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Aug. 02, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today [...]
Allscripts announces second quarter 2018 results
02/08/2018
Reported second quarter growth of 23% in GAAP revenue to $526 million, 25% in non-GAAP revenue to $536 million Second quarter GAAP EPS of $0.36, growth of 20% in non-GAAP EPS to $0.18 Announces new $250 million stock [...]
Diversicare Announces 2018 Second Quarter Results
02/08/2018
BRENTWOOD, Tenn., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the second quarter ended June 30, [...]
Cytori to Webcast Second Quarter Financial Results on August 14
02/08/2018
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Tuesday, August 14, 2018 at 5:30 PM [...]
Cerner Reports Second Quarter 2018 Results
02/08/2018
KANSAS CITY, Mo., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2018 second quarter that ended June 30, 2018. Bookings in the second quarter of 2018 were $1.775 [...]
Nuvectra™ Appoints Neuromodulation Veteran Ben Tranchina as Chief Technology Officer
02/08/2018
PLANO, Texas, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today the appointment of Ben Tranchina as Chief Technology Officer (CTO), [...]
Kiniksa Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference
02/08/2018
HAMILTON, Bermuda, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will be presenting at the 2018 Wedbush PacGrow Healthcare Conference on Tuesday, August 14 th , [...]
Paratek Pharmaceuticals Reports Second Quarter 2018 Financial Results
02/08/2018
-- Antimicrobial Drugs Advisory Committee of FDA scheduled for August 8, 2018 to review the Company's NDAs for omadacycline -- -- Omadacycline PDUFA action date scheduled for October 2018 -- -- Company on track for a [...]
Pacific Biosciences of California, Inc. Announces Second Quarter 2018 Financial Results
02/08/2018
MENLO PARK, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2018. Total revenue for the second [...]
IntelGenx to Report Second Quarter 2018 Financial Results on Aug 9, 2018 – Conference Call to Follow
02/08/2018
SAINT LAURENT, Quebec, Aug. 02, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its second quarter 2018 financial results after market close on [...]
Arbutus Reports 2018 Second Quarter Financial Results and Provides Corporate Update
02/08/2018
- Phase 1a/1b study of AB-506, a second-generation oral capsid inhibitor, initiated - Phase 1a/1b study of AB-452, a novel and proprietary oral RNA destabilizer, expected to begin in the second half of 2018 - All oral [...]
MannKind Corporation Reports 2018 Second Quarter Financial Results Conference Call to Begin Today at 5:00 PM ET
02/08/2018
2Q 2018 Afrezza Net Revenue was $3.8 million; 142% growth versus 2Q 2017 2Q 2018 Afrezza TRx grew 71% versus 2Q 2017 Debt principal reduced by $42.6 million, or 27%, year-to-date Successfully completed Phase 1 clinical [...]
Capricor Therapeutics to Present Second Quarter Financial Results and Corporate Update on August 9
02/08/2018
LOS ANGELES, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]
Tauriga Sciences Inc. Notified by FINRA that its Ticker Symbol will Revert to TAUG at Open of Market on Friday August 3, 2018
02/08/2018
NEW YORK, NY, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB: TAUG) (OTCQB: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
MPX Bioceutical Corporation Reports Financial Results for Its Fiscal Year 2018
02/08/2018
Company reports FY 2018 revenues of $21.3 million TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today reports financial results for its fiscal [...]
Bonify Signs Cannabis Concentrate Program Agreement With MediPharm Labs Inc.
02/08/2018
TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Inc. (" MediPharm " or the " Company ") is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement dated July 31, 2018 (the " [...]
Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile Infection
02/08/2018
Microbiome Damage Caused by Current Treatments May Lead to Disease Recurrence Ridinilazole Reduced Recurrence Rates by 59% versus Standard of Care Vancomycin OXFORD, U.K. and CAMBRIDGE, Mass., Aug. 02, 2018 (GLOBE [...]
CohBar, Inc. to Announce 2018 Second Quarter Financial Results and Host Conference Call for Shareholders on August 14, 2018
02/08/2018
MENLO PARK, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today [...]

Pages